Northwest Biotherapeutics (NASDAQ: NWBO) (“NW Bio”), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced…
Rockville's MacroGenics Inc. is moving deeper into the cancer immunotherapy space with a new big pharma partnership. The clinical-stage biopharmaceutical…